Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
214studies shown
Showing 49-60 of 214
Drug study icon
TerminatedNCT05518149

Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)

This study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.

In Australia
DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States, Australia, France, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT03345342

Paliperidone Palmitate 6-Month Formulation

This study is completed in the United States, in Australia, in France, .... It focuses on Schizophrenia.

In Australia
SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States, Australia, France, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00420823

Taurine for Schizophrenia

This study is completed in Australia. It is testing taurine for Schizophrenia.

In Australia
SchizophreniaDrugFrom 18 Years to 25 Years
Countries
Australia
Sponsor
Melbourne Health
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05120856

AAT-App Outpatient study

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online
AddictionBehavioralOver 18 Years
Countries
Australia
Sponsor
Turning Point
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.